BestGrowthStocks.Com Issues a Comprehensive Analysis of Tivic Health Systems Potential Catalysts
New York, New York
|
July 29, 2024 04:25 AM Eastern Daylight Time
NEW YORK, NY / NewsDirect / July 29, 2024 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a comprehensive analysis on Tivic Health Systems Inc. a health tech company that develops and commercializes bioelectronic medicine.
Tivic Health Systems Inc. (NASDAQ: TIVC) recently announced the expansion of its intellectual property portfolio with three new patents granted in the US and Europe.
Best Growth Stocks full report breaks through the noise and offers an extensive comprehensive analysis of Tivic Health Systems operations, potential catalysts, pipeline, patents, share structure, recent news events, growth strategy, financials, chart support and resistance zones, and more.
Access this full analysis free here: https://bestgrowthstocks.com/access-tivc-analysis/
Access the full analysis free here: https://bestgrowthstocks.com/access-tivc-analysis/
About Tivic
Tivic is a commercial health tech company advancing the field of bioelectronic medicine. Tivic’s patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Tivic’s non-invasive and targeted approach to the treatment of inflammatory chronic health conditions gives consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. Tivic’s first commercial product ClearUP is an FDA approved, award-winning, handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and is available through online retailers and commercial distributors. For more information visit http://tivichealth.com.
About Best Growth Stocks
Best Growth Stocks is a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing our exclusive ai-assisted research. BGS is also a financial news provider, focused on giving investors direct access to CEOs of promising, publicly-traded companies, and market experts. Our CEO interviews aim to answer the questions that rest on the minds of current and future shareholders. This is not to be construed as financial advice. Please consult with a licensed financial advisor before making any investment decisions.
Media Contact
Best Growth Stocks
Senior Editor: Steve Macalbry
Contact Details
Best Growth Stocks
Steve Macalbry
